Abstract
The current case describes an interesting event in a male patient in which detumescence of an ischemic priapism was obtained following an inadvertent intra-cavernosal injection of fentanyl mistaken for phenylephrine. Detumescence was achieved after injecting a total of 4.0 mls. Patient tolerated the procedure well and his vital signs were stable throughout the entire process. The possible causes of such an outcome as well as the miscommunication that has lead to such an injection are discussed.
Keywords: Ischemic low-flow priapism, detumescence, fentanyl, inadvertent, intra-cavernosal injection, erectile dysfunction (ED), prostate cancer
Current Drug Safety
Title: Achieving Detumescence of Ischemic Priapism with Intra-Cavernosal Injection of entanyl: An Unexpected Outcome of Miscommunication Error
Volume: 6 Issue: 3
Author(s): Tariq F. Al-Shaiji
Affiliation:
Keywords: Ischemic low-flow priapism, detumescence, fentanyl, inadvertent, intra-cavernosal injection, erectile dysfunction (ED), prostate cancer
Abstract: The current case describes an interesting event in a male patient in which detumescence of an ischemic priapism was obtained following an inadvertent intra-cavernosal injection of fentanyl mistaken for phenylephrine. Detumescence was achieved after injecting a total of 4.0 mls. Patient tolerated the procedure well and his vital signs were stable throughout the entire process. The possible causes of such an outcome as well as the miscommunication that has lead to such an injection are discussed.
Export Options
About this article
Cite this article as:
F. Al-Shaiji Tariq, Achieving Detumescence of Ischemic Priapism with Intra-Cavernosal Injection of entanyl: An Unexpected Outcome of Miscommunication Error, Current Drug Safety 2011; 6 (3) . https://dx.doi.org/10.2174/157488611797579311
DOI https://dx.doi.org/10.2174/157488611797579311 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prophylactic Neuroprotection
Current Drug Targets The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Anti-Cancer Agents in Medicinal Chemistry Antisense Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Current Concepts in SLE Thrombocytopenia: From Pathophysiology to Therapeutic Interventions
Current Rheumatology Reviews Dexmedetomidine: A Review of its Use for the Management of Pain, Agitation, and Delirium in the Intensive Care Unit
Current Pharmaceutical Design New Drugs for Epidural Analgesia
Current Drug Targets Microdialysis in Drug Discovery
Current Drug Discovery Technologies Saltatory and Sinusoidal Fetal Heart Rate (FHR) Patterns and significance of FHR ‘Overshoots’
Current Women`s Health Reviews Perioperative Management of Obese Parturients
Current Women`s Health Reviews Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems
Current Pharmaceutical Design Crystallization and Preliminary Crystallographic Studies of an Antitumour Lectin from the Edible Mushroom Agrocybe aegerita
Protein & Peptide Letters Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Safety and Efficacy of Melatonin in Pediatric Migraine Prophylaxis
Current Drug Safety Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences
Cardiovascular & Hematological Agents in Medicinal Chemistry Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis
Current Pharmaceutical Design PPARγ in Angiogenesis and Vascular Development
Current Angiogenesis (Discontinued)